The private equity industry in Asia is bifurcating on various trend lines around fundraising, exits, and institutionalization. GPs may require a more complex playbook to survive and thrive
Polarization has been a characteristic of Asian private equity for the best part of a decade. It is usually most starkly expressed in fundraising statistics, and 2018 was arguably the most polarized year...
Singapore-based start-up incubator Antler will launch operations in India later in the year and plans to raise upto $50 million to invest in start-ups in the country.
Genor Biopharma, a Shanghai-based innovative drug developer, has raised $160 million in Series B funding led by Hillhouse Capital.
Fullerton India Credit (FICC), an Indian non-banking financial company (NBFC) owned by Singapore's Temasek Holdings, has raised INR7.5 billion ($100 million) in funding from its parent.
Beam, a Singapore-headquartered ride-sharing platform for e-scooters, has raised $26 million in a Series A funding round led by Sequoia Capital India and Hana Ventures.